High-Dose Inactivated Influenza Vaccine Linked to Lower Rates of Hospitalization in HF
Patients with heart failure who receive a high-dose inactivated influenza vaccine have a decreased risk for hospitalization.
According to a study in Circulation: Heart Failure, high-dose inactivated influenza vaccine (HD-IIV) is associated with reduced rates of hospitalizations related to laboratory-confirmed influenza, cardiorespiratory disease, cardiovascular (CV) disease, and heart failure (HF) in patients with HF.
- The study analyzed data from the DANFLU-2 trial conducted in Denmark during 3 consecutive influenza seasons (2022-2025).
- The trial included individuals aged 65 years and older who were randomly assigned to receive HD-IIV or standard-dose inactivated influenza vaccine (SD-IIV).
No direct quote available in the text.
Author's summary: High-dose flu vaccine reduces hospitalization risk in heart failure patients.
More News
- When a Victorian ghost hunter investigated Britain’s most haunted house, this is what he found
- The Knicks are seeing the true value of Miles McBride during his absence
- NBA approves $10 billion Lakers sale to Mark Walter
- CULTURE CLUB: Peninsula Music Festival: Balancing the Baton - Door County Pulse
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- Do Sonny and Justine Belong Together on GH? Fans Have Their Say - Soap Opera Digest
- Flau’jae Johnson Shuts Down Governor’s Call for Charlie Kirk Statue at LSU, Social Media Rides With Her
- A Journey Through the Arab World’s Most Beloved Breads
- Romero Elementary stage shines with creativity at pumpkin decorating contest
- And the Winner Is… The Local’s 2nd Annual Halloween Decorating Showdown Champion